MIM
Marco Investment Management Portfolio holdings
AUM
$1.2B
This Quarter Return
-11.65%
1 Year Return
+22.28%
3 Year Return
+87.03%
5 Year Return
+157.96%
10 Year Return
+313.92%
AUM
$504M
AUM Growth
+$504M
(-28%)
Cap. Flow
-$102M
Cap. Flow
% of AUM
-20.15%
Top 10 Holdings %
Top 10 Hldgs %
29.54%
Holding
194
New
3
Increased
27
Reduced
116
Closed
23
Top Buys
| 1 |
Cigna
CI
|
$2.33M |
| 2 |
Enterprise Products Partners
EPD
|
$2.05M |
| 3 |
International Flavors & Fragrances
IFF
|
$589K |
| 4 |
TJX Companies
TJX
|
$487K |
| 5 |
Target
TGT
|
$256K |
Top Sells
| 1 |
AGN
Allergan plc
AGN
|
$13.5M |
| 2 |
Goldman Sachs
GS
|
$8.62M |
| 3 |
ESRX
Express Scripts Holding Company
ESRX
|
$7.59M |
| 4 |
Albemarle
ALB
|
$6.59M |
| 5 |
Gilead Sciences
GILD
|
$6.35M |
Sector Composition
| 1 | Technology | 21.43% |
| 2 | Healthcare | 18.57% |
| 3 | Financials | 11.32% |
| 4 | Consumer Staples | 9.71% |
| 5 | Industrials | 8.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ENDP
151
DELISTED
Endo International plc
ENDP
| $293K | 0.06% |
40,100
-13,000
| -24% | -$95K |
|
152
Micron Technology
MU
$133B
| $264K | 0.05% |
8,315
-173,500
| -95% | -$5.51M |
|
|
153
Target
TGT
$42B
| $256K | 0.05% |
+3,867
| New | +$256K |
|
154
Mondelez International
MDLZ
$80B
| $249K | 0.05% |
6,219
+759
| +14% | +$30.4K |
|
155
Eli Lilly
LLY
$659B
| $247K | 0.05% |
2,135
-19
| -0.9% | -$2.2K |
|
156
Transocean
RIG
$2.89B
| $246K | 0.05% |
35,500
-20,400
| -36% | -$141K |
|
|
AABA
157
DELISTED
Altaba Inc. Common Stock
AABA
| $242K | 0.05% |
4,184
| – | – |
|
158
DexCom
DXCM
$29.1B
| $240K | 0.05% |
2,000
-500
| -20% | -$60K |
|
159
Weyerhaeuser
WY
$18B
| $240K | 0.05% |
10,999
-1,920
| -15% | -$41.9K |
|
160
Nuveen S&P 500 Buy-Write Income Fund
BXMX
$1.48B
| $227K | 0.05% |
18,766
| – | – |
|
161
3M
MMM
$82.2B
| $224K | 0.04% |
1,175
-305
| -21% | -$58.1K |
|
162
Equity Residential
EQR
$24.4B
| $212K | 0.04% |
3,214
-27
| -0.8% | -$1.78K |
|
163
Yum! Brands
YUM
$40.4B
| $212K | 0.04% |
2,302
| – | – |
|
164
Exponent
EXPO
$3.63B
| $205K | 0.04% |
4,050
| – | – |
|
165
Codexis
CDXS
$227M
| $167K | 0.03% |
10,000
| – | – |
|
166
Ford
F
$46.6B
| $99K | 0.02% |
13,000
-1,096
| -8% | -$8.35K |
|
167
GE Aerospace
GE
$292B
| $96K | 0.02% |
12,733
-8,258
| -39% | -$62.3K |
|
168
CVR Partners
UAN
$945M
| $77K | 0.02% |
22,500
| – | – |
|
169
Akebia Therapeutics
AKBA
$825M
| $76K | 0.02% |
+13,654
| New | +$76K |
|
170
DarioHealth
DRIO
$22M
| $39K | 0.01% |
50,000
+25,000
| +100% | +$19.5K |
|
|
PVL
171
Permianville Royalty Trust
PVL
$65.3M
| $23K | ﹤0.01% |
12,000
-4,000
| -25% | -$7.67K |
|
172
MiMedx Group
MDXG
$1.06B
| – | – |
-10,000
| Closed | -$62K |
|
|
173
Albemarle
ALB
$9.36B
| – | – |
-66,000
| Closed | -$6.59M |
|
174
AMERISAFE
AMSF
$870M
| – | – |
-3,350
| Closed | -$208K |
|
175
Broadridge
BR
$29.5B
| – | – |
-2,113
| Closed | -$279K |
|